Airsculpt Technologies, Inc. (AIRS) stock
AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3084% below fair value
$0.74+0.04 (+5.53%)
Close on Nov 17, 2026Market cap $53.26MP/E –Yield –
Airsculpt Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Airsculpt Technologies's ebitda for the twelve months ending Jun 30, 2026 was -$333.00K, down 107.8% year over year. For fiscal 2025 it was $1.22M, down 88.2% from the year before. The highest annual figure on record is $22.37M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.22M | -88.2% |
| FY2024 | Dec 31, 2024 | $10.31M | -48.4% |
| FY2023 | Dec 31, 2023 | $19.98M | +468.1% |
| FY2022 | Dec 31, 2022 | $3.52M | -84.3% |
| FY2021 | Dec 31, 2021 | $22.37M | +42.7% |
| FY2020 | Dec 31, 2020 | $15.67M | +178.7% |
| FY2019 | Dec 31, 2019 | $5.62M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.91M | -27.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.22M | -26.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.53M | – |
| Q2 FY2025 | Jun 30, 2025 | $4.03M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.65M | -88.0% |
| Q4 FY2024 | Dec 31, 2024 | -$703.00K | -115.9% |
| Q3 FY2024 | Sep 30, 2024 | -$713.00K | -119.9% |
| Q2 FY2024 | Jun 30, 2024 | -$2.10M | -126.6% |
| Q1 FY2024 | Mar 31, 2024 | $13.82M | +237.2% |
| Q4 FY2023 | Dec 31, 2023 | $4.42M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.58M | +479.0% |
| Q2 FY2023 | Jun 30, 2023 | $7.88M | +32.9% |
| Q1 FY2023 | Mar 31, 2023 | $4.10M | +473.1% |
| Q4 FY2022 | Dec 31, 2022 | -$3.74M | – |
| Q3 FY2022 | Sep 30, 2022 | $619.00K | -94.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.93M | -53.5% |
| Q1 FY2022 | Mar 31, 2022 | $715.00K | -91.8% |
| Q4 FY2021 | Dec 31, 2021 | -$10.32M | – |
| Q3 FY2021 | Sep 30, 2021 | $11.26M | – |
| Q2 FY2021 | Jun 30, 2021 | $12.73M | – |
| Q1 FY2021 | Mar 31, 2021 | $8.70M | – |
See a number that looks wrong?